• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

efficacy and role of signaling pathway by SOCS3-CKO in myocardial ischemia repercussion injury

Research Project

Project/Area Number 24791957
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Emergency medicine
Research InstitutionKurume University

Principal Investigator

NAGATA Takanobu  久留米大学, 医学部, 助教 (50535078)

Project Period (FY) 2012-04-01 – 2014-03-31
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywordsアポトーシス / シグナル / 救急医学 / 集中治療医学
Research Abstract

We investigated the role of myocardial suppressor of cytokine signaling-3 (SOCS3), an intrinsic negative feedback regulator of the JAK-STAT signaling pathway, in the pathophysiology of myocardial ischemia-reperfusion(I/R) injury. Activation of cardioprotective signaling pathways including STAT3, AKT, and ERK1/2 were rapidly peaked and was inactivated after I/R. Although the initial infarct size after coronary occlusion determined by triphenyltetrazolium chloride staining was comparable between control and cardiac-specific SOCS3 knockout mice (SOCS3-CKO), the infarct size 24 h after I/R was reduced by approximately 30% in SOCS3-CKO mice, indicating that progression of myocardial I/R injury was prevented in SOCS3-CKO hearts. Cardiac-specific SOCS3 deletion enhanced multiple cardioprotective signaling pathways including STAT3, AKT and ERK1/2 while inhibiting myocardial apoptosis.

Report

(3 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • Research Products

    (17 results)

All 2013 2012

All Journal Article (9 results) (of which Peer Reviewed: 9 results) Presentation (8 results)

  • [Journal Article] Screening for Fabry disease in patients with left ventricular hypertrophy.2013

    • Author(s)
      Mawatari K, Nagata T
    • Journal Title

      Int J Cardiol

      Volume: 3 Pages: 1059-1061

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Screening for Fabry disease in patients with left ventricular hypertrophy.2013

    • Author(s)
      Mawatari K, Yasukawa H, Oba T, Nagata T, Togawa T, Tsukimura T, Kyogoku S, Ohshima H, Minami T, Sugi Y, Sakuraba H, Imaizumi T.
    • Journal Title

      Int J Cardiol

      Volume: 167 Issue: 3 Pages: 1059-1061

    • DOI

      10.1016/j.ijcard.2012.10.076

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice2012

    • Author(s)
      Ohmura H, Yasukawa H, Minami T, Sugi Y, Oba T, Nagata T, Kyogoku S, Ohshima H, Aoki H, Imaizumi T
    • Journal Title

      Hypertens Res

      Volume: 35(11) Pages: 1063-1068

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction2012

    • Author(s)
      Fukui D, Yasukawa H, Sugi Y, Oba T, Nagata T, Kyogoku S, Futamata N, Yokoyama T, Yokoyama S, Kai H, Ueno T, Kage M, Imaizumi T
    • Journal Title

      Int J Cardiol

      Volume: 160(3) Pages: 216-219

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction2012

    • Author(s)
      Oba T, Yasukawa H, Hoshijima M, Sasaki K, Futamata N, Fukui D, Mawatari K, Nagata T, Kyogoku S, Ohshima H, Minami T, Nakamura K, Kang D, Yajima T, Knowlton KU, Imaizumi T
    • Journal Title

      J Am Coll Cardiol

      Volume: 59(9) Pages: 838-852

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction.2012

    • Author(s)
      Oba T, Yasukawa H, Hoshijima M, Sasaki KI, Futamata N, Fukui D, Mawatari K, Nagata T, Kyogoku S, Ohshima H, Minami T, Nakamura K, Kang D, Yajima T, Knowlton KU, Imaizumi T
    • Journal Title

      J Am Coll Cardiol

      Volume: 59 Pages: 838-852

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.2012

    • Author(s)
      Ohmura H, Yasukawa H, Minami T, Sugi Y, Oba T, Nagata T, Kyogoku S, Ohshima H, Aoki H, Imaizumi T
    • Journal Title

      Hypertens Res

      Volume: 35 Pages: 1063-1068

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction.2012

    • Author(s)
      Fukui D, Yasukawa H, Sugi Y, Nagata T, Kyogoku S, Futamata N, Oba T, Yokoyama T, Yokoyama S, Ueno T, Kage M, Imaizumi T
    • Journal Title

      Int J Cardiol

      Volume: 160 Pages: 216-219

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] SOCS3: a novel therapeutic target for cardioprotection.2012

    • Author(s)
      Yasukawa H, Nagata T, Oba T, Imaizumi T
    • Journal Title

      Jak-Stat

      Volume: 1 Pages: 234-240

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] Screening for fabry disease in patients with left ventricular hypertrophy.2013

    • Author(s)
      馬渡一寿、永田隆信
    • Organizer
      第17回に本心不全学会学術集会
    • Place of Presentation
      埼玉
    • Related Report
      2013 Annual Research Report
  • [Presentation] Cardiac-specific deletion of suppressor of cytokine signaling-3 prevents doxorubisin-induced cardiomyopathy in mice2012

    • Author(s)
      Kyogoku S, Yasukawa H, Nagata T, Oba T, Ohshima H, Minami T, Yajima T, Hoshijima M, Aoki H, Knowlton KU, Imaizumi T
    • Organizer
      The American Heart Association, The 85th Scientific Sessions
    • Place of Presentation
      Los Angeles, USA
    • Related Report
      2013 Final Research Report
  • [Presentation] Pioglitazone decreases plasma fibroblast growth factor-21 levels in patients with type 2 diabetes2012

    • Author(s)
      Mawatari K, Tahara N, Yasukawa H, Oba T, Nagata T, Kyogoku S, Ohshima H, Minami T, Mizoguchi M, Sugi Y, Adachi H, Imaizumi T
    • Organizer
      The American Heart Association, The 85th Scientific Sessions
    • Place of Presentation
      Los Angeles, USA
    • Related Report
      2013 Final Research Report
  • [Presentation] Prevention of doxorubicin-induced cardiomyopathy in cardiac-specific SOCS3 deficient mice by preserving energy metabolism2012

    • Author(s)
      Kyogoku S, Yasukawa H, Nagata T, Oba T, Ohshima H, Minami T, Fukui D, Sugi Y, Aoki H, Imaizumi T
    • Organizer
      第29回国際心臓研究学会(ISHR)日本部会総会
    • Place of Presentation
      福岡
    • Related Report
      2013 Final Research Report
  • [Presentation] Cardiac-Specific Deletion of Suppressor of Cytokine Signaling-3 Prevents Doxorubicin-Induced Cardiomyopathy in Mice.2012

    • Author(s)
      Kyogoku S, Yasukawa H, Nagata T, Oba T, Ohshima H, Minami T, Yajima T, Hoshijima M, Aoki H, Knowlton KU, Imaizumi T
    • Organizer
      The American Heart Association, The 85th Scientific Sessions
    • Place of Presentation
      Los Angels, USA
    • Related Report
      2012 Research-status Report
  • [Presentation] Pioglitazone Decrease Plasma Fibroblast Growth Factor-21 Levels in Patients with Type 22012

    • Author(s)
      Mawatari K, Tahara N, Yasukawa H, Oba T, Nagata T, Kyogoku S, Ohshima H, Minami T, Mizoguchi M, Sugi Y, Adachi H, Imaizumi T
    • Organizer
      The American Heart Association, The 85th Scientific Sessions
    • Place of Presentation
      Los Angels, USA
    • Related Report
      2012 Research-status Report
  • [Presentation] Prevention of Doxorubicin-induced Cardiomyopathy in Cardiac-Specific SOCS3 Deficient Mice by Preserving Energy Metabolism.2012

    • Author(s)
      Kyogoku S, Yasukawa H, Nagata T, Oba T, Ohshima H, Minami T, Fukui D, Sugi Y, Aoki H, Imaizumi T
    • Organizer
      第29回 国際心臓研究学会 ISHR 日本部会総会
    • Place of Presentation
      福岡
    • Related Report
      2012 Research-status Report
  • [Presentation] Prevention of Doxorubicin-Induced Cardiomyopathy in Cardiac-Specific SOCS3 Deficient Mice by Augmenting STAT3 Signaling Pathway2012

    • Author(s)
      京極 幸子、安川秀雄、永田隆信、大場豊治、大島英樹、南知子、福井大介、杉雄介、青木浩樹、今泉勉
    • Organizer
      第36回 心筋代謝研究会
    • Place of Presentation
      東京
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi